As a member of The Health Charities Coalition of Canada (HCCC) our organization, Osteoporosis Canada, is pleased to see federal support for the establishment of the Canadian Drug Agency which […]

Board of Directors Jeannette Briggs Chair | Oakville, ON Jeannette has more than 25 years of experience working in the energy sector.  She has held a wide-range of jobs within […]

Available Volunteer Opportunities Support Group Facilitator – Virtual Support Group Facilitators work together with the Community Engagement Coordinators and are an integral part in the delivery of support services. Groups […]

Advocate Educate, empower and support In keeping with our mission to educate, empower and support individuals and communities in the prevention and treatment of osteoporosis, Osteoporosis Canada communicates concerns about various […]

Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, Dr. Emma Billington and Dr. Wendy Ward. Recommendations from Osteoporosis Canada Rapid Response Team. LeBoff and colleagues (1) […]

Community Backbone Award Form Recipients of the Community Backbone Award recognize individuals who volunteer in communities across the country who, through their actions, efforts and ideas, have made a significant […]

SAC Newsletter SAC Link The SAC Link is a quarterly newsletter for members of Osteoporosis Canada’s Scientific Advisory Council. It includes Osteoporosis Canada news, updates from committees and member news. […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]